Just ask Rebecca Cherubini. She has been struggling with multiple sclerosis for 15 years.

"I surrendered it to God," she said, "I'm like, 'If this is your will, I would love for You to change it. But if not, ok, then You need to give me the grace to deal.'"

Like most people with MS, Cherubini's came out of the blue when she was young.

"Blurred vision to the point where I started to become nervous about my driving," she recalled. "And then one day I was actually going to work and I pulled off."

In addition to vision problems, other symptoms include fatigue, trouble walking and difficulty thinking.

MS is an autoimmune disease. That's when the body's immune system mistakenly attacks healthy tissue. In the case of MS, the immune system attacks the outer portion of nerves in the brain and the spinal cord. It gets worse over time, and there is no cure.

"I want to be able to drive my kids to soccer," Cherubini said. "I don't want to be debilitated. I don't want to be in a wheelchair."

Now, Cherubini may get her wish. She's one of dozens of MS patients at the Ohio State Medical Center to test a new drug called Ocrelizumab.

The medicine works to stop the cells in the immune system from attacking the central nervous system. It's clearly effective. It's been shown to stop the disease in its tracks—not just the more common "relapsing" form of MS, but also the most aggressive type, called "primary progressive."

"Ocrelizumab was the first medication for primary progressive MS that actually worked," said Dr. Michael Racke, a neurologist at the Ohio State Wexner Medical Center who has been treating MS patients for 30 years.

He says patients call it a game-changer.

"They say, 'You know, I really haven't had any kinds of effects from my MS,' and that's really obviously quite satisfying as an MS physician who can remember the days when we really didn't have anything to treat patients," he said.

Cherubini told Dr. Racke she's delighted the drug has stopped the progression of her disease. (Screengrab: Ocrelizumab/via CBN News)

"I feel normal again. I was telling him, I just feel normal," she said.

Ocrelizumab is not like other MS drugs, such as the pills that have to be taken daily or the shots that come three times a week. It only involves an infusion, which typically lasts four hours, every six months.

"This medicine, I don't have to worry about it," Cherubini said. "I don't have to take it every day. I don't have to worry about ordering it. I don't have to worry about any reactions to it."

Ocrelizumab costs $65,000 a year, which believe it or not, is less than many of the leading MS drugs.

And while this breakthrough can stop the progression of MS, doctors still don't know what causes the disease, so prevention remains a mystery.

"If you look at identical twins, when one twin gets MS, 70 percent of the time the other identical twin, who clearly has the same genetics as their brother or sister, doesn't get MS," explained Dr. Racke.

Since MS is an inflammatory disease, things that cause inflammation, such as obesity, stress and smoking, could factor-in. Early studies show vitamin D might help prevent it.

To receive daily emails from Breaking Christian News to your inbox CLICK HERE

Long Beach, California Cancels Their Popular July 4th Fireworks Show, Even for America's 250th Birthday, Citing Pollution as the Reason

Digital Nightmare? Anthropic Withholds AI Model Too Dangerous for Humanity

'A Victory for All Pro-Life Oregonians': Federal Judge Rules State Can't Force Oregon Right to Life to Pay for Abortions

10 Republicans Side With Dems to Provide Amnesty to Haitian Illegals

Virginia Dems Pass National Popular Vote Law that Experts Warn Is Unconstitutional

Israel-Lebanon Ceasefire Begins; Trump Says Iran's Regime Agrees to Give Up Having Nuclear Weapons

President Trump: Strait of Hormuz 'Fully Open', Oil Prices Drop

Clarence Thomas Destroys 'Progressivism' in Ruthless Speech

Trump Reveals He Has Multi-Pick SCOTUS Plan Ready as Justice Retirement Speculation Heats Up

Trump Admin Pushes Global Plan to Protect Kids Online

Youth Mental Health Deteriorates after Gender Reassignment Services, Extensive, Long-Term Study Finds

Trump Administration Pulls $11 Million in Funding for Catholic Charities that Sheltered Illegal Alien Minors

Prayer Alert: Former Democrat Lt. Gov. and Wife Found Dead in Apparent Murder-Suicide; Kids Were Home at the Time

Israeli Forces Discover Huge Hezbollah Weapons Cache Inside School; Destroy 70 Hezbollah Terror Sites in Lebanon

US War on Iran's Regime Could Be Ending Soon; Ceasefire between Israel and Lebanon Announced

Melania Trump Joins Lawmakers for Roundtable Discussion on Empowering Foster Care Children

Heroic Oklahoma High School Principal Shot in the Leg as He Tackles Would-Be Shooter Before Gunman Opens Fire on Students (VIDEO)

Teachers' Union Webinar Sparks Indoctrination Fears

'Deadnaming' Is Now Classified as 'Gender-Based Violence' in Liberal Canada

The War on Biology Is Far from Over